Aethlon Medical, Inc.

Stage 1 · Basing · week 4

As of Oct 22, 2026, Aethlon Medical is in Stage 1, the basing phase, now in week 4 (since Sep 30, 2026). It closed at $5.19, 81.9% below its 52-week high and below its 200-day average, which is falling.

Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices in the United States. More about the company

$5.19

+3.39% today

$8.3M · Micro cap

Market Neutral — Building

Pro read

Pro

Our read

Basing, not in an uptrend yet

Setup score

—

Momentum

Steady

Edge

—

Is AEMD early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2023-08-16 → 2026-10-22

S4 18w

S4 33w

S4 54w

S4 14w

2023-08-162026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S1 1w → S4 18w → S1 7w → S4 33w → S1 4w → S4 4w → S1 1w → S4 2w → S1 5w → S2 7w → S3 5w → S4 54w → S1 7w → S4 14w → S1 3w current

Total tracked: 166 weeks across 15 stage runs.

AEMD among Medical Devices108th of 141 by relative strength

All 141 →

Stocks in Medical Devices ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	TXG10x Genomics, Inc.	Stage 2 · wk 48	99	−7.8%
2	RCELAvita Medical, Inc.	Stage 2 · wk 13	98	+40.8%
3	BFLYButterfly Network, Inc. Class A	Stage 2 · wk 26	98	−26.0%
4	HAEHaemonetics Corporation	Stage 2 · wk 17	96	+8.7%
5	GKOSGlaukos Corporation	Stage 2 · wk 25	96	+15.1%
6	AXGNAxogen, Inc.	Stage 3 · wk 2	95	−15.3%
7	NEOGNeogen Corporation	Stage 2 · wk 14	95	−11.7%
8	BVSBioventus Inc. Class A	Stage 2 · wk 15	95	+10.5%
…108	AEMDAethlon Medical, Inc.	Stage 1 · wk 4	12	−23.8%

vs 52W High

-81.9%

$1.43 lo$28.75 hi

81.9% below 52W high

Stock is basing below old highs. A volume-backed breakout to new highs would be the Stage 2 signal to watch.

Stage Maturity

Week 4

1w13w26w

Week 4, early base

How long this stock has been basing. Longer bases can produce stronger breakouts, but the breakout itself is the signal.

vs 200 DMA

-35.1%

200 DMA: $8.00 · sloping down

Stock is testing its 200 DMA as part of the base. Reclaiming and holding above it is a key Stage 2 prerequisite.

Rel Volume

0.06x

vs 50-day avg

Volume in Stage 1 basing is typically quiet. A surge in volume on an upside breakout is the signal to watch.

Trend Health

↑

Short-term trend rising strongly

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

-23.8%

+79.0%

-53.9%

YTD

-63.2%

-79.3%

Scan Membership

Breakout Watch

Latest: 2025-01-31

4 appearances in last 60 days. First seen: 2019-01-02.

A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.

Recent Stage Timeline

2026-10-22S1

Wk 4 · Vol 0.06x

2026-10-21S1

Wk 4 · Vol 0.01x

2026-10-20S1

Wk 3 · Vol 0.01x

2026-10-19S1

Wk 3 · Vol 0.03x

2026-10-16S1

Wk 3 · Vol 0.01x

2026-10-15S1

Wk 3 · Vol 0.02x

2026-10-14S1

Wk 3 · Vol 0.04x

2026-10-13S1

Wk 2 · Vol 0.01x

2026-10-12S1

Wk 2 · Vol 0.01x

2026-10-09S1

Wk 2 · Vol 0.00x

2026-10-08S1

Wk 2 · Vol 0.01x

2026-10-07S1

Wk 2 · Vol 0.01x

Moving averages & range

50 DMA

$4.18

200 DMA

$8.00

52W High

$28.75

52W Low

$1.43

5D Low

$5.02

Resistance levels (recent highs)

20d High

$6.63

60d High

$6.81

120d High

$15.35

250d High

$28.75

Next resistance

+27.7%

to 20d High

ROE

-160.9%

Profit margin 0.0%

Dividend Yield

0.00%

P/B 0.5

Aethlon Medical: quick answers

What stage is Aethlon Medical in?

As of Oct 22, 2026, Aethlon Medical (AEMD) is in Stage 1, the basing phase. It entered Stage 1 on Sep 30, 2026 and is in week 4. What the four stages mean

Is Aethlon Medical in an uptrend?

Not yet. Aethlon Medical is in Stage 1, a base that can come before an uptrend. It trades 35.1% below its 200-day average, which is falling.

How far is Aethlon Medical from its 52-week high?

Aethlon Medical closed at $5.19 on Oct 22, 2026, 81.9% below its 52-week high of $28.75. Its 52-week low is $1.43.

How has Aethlon Medical performed over the past year?

As of Oct 22, 2026, Aethlon Medical is down 79.3% over the past year and down 63.2% so far in 2026.

Which sector and industry is Aethlon Medical in?

Aethlon Medical is in the Medical Devices industry, part of the Health Care sector.

About this companyHealth Care· Medical Devices

Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation, and other disease states. The company was founded in 1984 and is based in San Diego, California.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.